196 related articles for article (PubMed ID: 23708010)
1. Elaboration of thorough simplified vinca alkaloids as antimitotic agents based on pharmacophore similarity.
Zheng J; Deng L; Chen M; Xiao X; Xiao S; Guo C; Xiao G; Bai L; Ye W; Zhang D; Chen H
Eur J Med Chem; 2013 Jul; 65():158-67. PubMed ID: 23708010
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F
J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SAR of vinca alkaloid analogues.
Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
[TBL] [Abstract][Full Text] [Related]
4. Total synthesis and biological evaluation of jerantinine E.
Frei R; Staedler D; Raja A; Franke R; Sasse F; Gerber-Lemaire S; Waser J
Angew Chem Int Ed Engl; 2013 Dec; 52(50):13373-6. PubMed ID: 24127420
[No Abstract] [Full Text] [Related]
5. Synthesis and biological evaluation of combretastatin-amidobenzothiazole conjugates as potential anticancer agents.
Kamal A; Mallareddy A; Janaki Ramaiah M; Pushpavalli SN; Suresh P; Kishor C; Murty JN; Rao NS; Ghosh S; Addlagatta A; Pal-Bhadra M
Eur J Med Chem; 2012 Oct; 56():166-78. PubMed ID: 22982122
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 6H-pyrido[2',1':2,3]imidazo[4,5-c]isoquinolin-5(6H)-ones as antimitotic agents and inhibitors of tubulin polymerization.
Meng T; Wang W; Zhang Z; Ma L; Zhang Y; Miao Z; Shen J
Bioorg Med Chem; 2014 Jan; 22(2):848-55. PubMed ID: 24360827
[TBL] [Abstract][Full Text] [Related]
7. Aroyl hydrazones of 2-phenylindole-3-carbaldehydes as novel antimitotic agents.
Vogel S; Kaufmann D; Pojarová M; Müller C; Pfaller T; Kühne S; Bednarski PJ; von Angerer E
Bioorg Med Chem; 2008 Jun; 16(12):6436-47. PubMed ID: 18513974
[TBL] [Abstract][Full Text] [Related]
8. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents.
Kumar GB; Nayak VL; Sayeed IB; Reddy VS; Shaik AB; Mahesh R; Baig MF; Shareef MA; Ravikumar A; Kamal A
Bioorg Med Chem; 2016 Apr; 24(8):1729-40. PubMed ID: 26970659
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of chalcone-amidobenzothiazole conjugates as antimitotic and apoptotic inducing agents.
Kamal A; Mallareddy A; Suresh P; Shaik TB; Lakshma Nayak V; Kishor C; Shetti RV; Sankara Rao N; Tamboli JR; Ramakrishna S; Addlagatta A
Bioorg Med Chem; 2012 Jun; 20(11):3480-92. PubMed ID: 22543234
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization.
Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E
J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, antitumor activity and safety testing of novel polyphosphoesters bearing anthracene-derived aminophosphonate units.
Kraicheva I; Vodenicharova E; Shenkov S; Tashev E; Tosheva T; Tsacheva I; Kril A; Topashka-Ancheva M; Georgieva A; Iliev I; Vladov I; Gerasimova Ts; Troev K
Bioorg Med Chem; 2014 Jan; 22(2):874-82. PubMed ID: 24365391
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
Kamal A; Suresh P; Mallareddy A; Kumar BA; Reddy PV; Raju P; Tamboli JR; Shaik TB; Jain N; Kalivendi SV
Bioorg Med Chem; 2011 Apr; 19(7):2349-58. PubMed ID: 21402478
[TBL] [Abstract][Full Text] [Related]
14. Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloids.
Coderch C; Morreale A; Gago F
Anticancer Agents Med Chem; 2012 Mar; 12(3):219-25. PubMed ID: 22044006
[TBL] [Abstract][Full Text] [Related]
15. Elaboration of simplified vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Thoret S; Guéritte F
Chem Biol Drug Des; 2010 Mar; 75(3):284-94. PubMed ID: 20659111
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.
Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP
ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of resveratrol-based nitrovinylstilbenes as antimitotic agents.
Reddy MA; Jain N; Yada D; Kishore C; Vangala JR; P Surendra R; Addlagatta A; Kalivendi SV; Sreedhar B
J Med Chem; 2011 Oct; 54(19):6751-60. PubMed ID: 21851083
[TBL] [Abstract][Full Text] [Related]
18. Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines.
Ouyang X; Piatnitski EL; Pattaropong V; Chen X; He HY; Kiselyov AS; Velankar A; Kawakami J; Labelle M; Smith L; Lohman J; Lee SP; Malikzay A; Fleming J; Gerlak J; Wang Y; Rosler RL; Zhou K; Mitelman S; Camara M; Surguladze D; Doody JF; Tuma MC
Bioorg Med Chem Lett; 2006 Mar; 16(5):1191-6. PubMed ID: 16377187
[TBL] [Abstract][Full Text] [Related]
19. Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship.
Leamon CP; Vlahov IR; Reddy JA; Vetzel M; Santhapuram HK; You F; Bloomfield A; Dorton R; Nelson M; Kleindl P; Vaughn JF; Westrick E
Bioconjug Chem; 2014 Mar; 25(3):560-8. PubMed ID: 24564229
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of carbazole sulfonamides as a novel class of antimitotic agents against solid tumors.
Hu L; Li ZR; Li Y; Qu J; Ling YH; Jiang JD; Boykin DW
J Med Chem; 2006 Oct; 49(21):6273-82. PubMed ID: 17034133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]